Jim Simons’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,371,400
| Closed | -$2.8M | – | 4390 |
|
|
2021
Q3 | $2.8M | Sell |
1,371,400
-56,500
| -4% | -$132K | ﹤0.01% | 1843 |
|
|
2021
Q2 | $4.24M | Sell |
1,427,900
-118,390
| -8% | -$313K | 0.01% | 1729 |
|
|
2021
Q1 | $4.27M | Sell |
1,546,290
-642,910
| -29% | -$1.94M | 0.01% | 1746 |
|
|
2020
Q4 | $5.32M | Buy |
2,189,200
+620,011
| +40% | +$1.49M | 0.01% | 1545 |
|
|
2020
Q3 | $3.29M | Buy |
1,569,189
+314,589
| +25% | +$1.06M | ﹤0.01% | 1826 |
|
|
2020
Q2 | $4.74M | Buy |
1,254,600
+290,272
| +30% | +$870K | ﹤0.01% | 1672 |
|
|
2020
Q1 | $1.82M | Buy |
964,328
+322,728
| +50% | +$839K | ﹤0.01% | 2096 |
|
|
2019
Q4 | $1.34M | Buy |
641,600
+434,800
| +210% | +$834K | ﹤0.01% | 2498 |
|
|
2019
Q3 | $494K | Buy |
206,800
+40,500
| +24% | +$109K | ﹤0.01% | 2874 |
|
|
2019
Q2 | $521K | Buy |
166,300
+112,300
| +208% | +$412K | ﹤0.01% | 2978 |
|
|
2019
Q1 | $269K | Buy |
+54,000
| New | +$266K | ﹤0.01% | 3129 |
|
|
2018
Q4 | – | Sell |
-82,800
| Closed | -$402K | – | 3720 |
|
|
2018
Q3 | $402K | Sell |
82,800
-89,600
| -52% | -$458K | ﹤0.01% | 2921 |
|
|
2018
Q2 | $1.03M | Buy |
172,400
+52,800
| +44% | +$386K | ﹤0.01% | 2587 |
|
|
2018
Q1 | $1.06M | Buy |
+119,600
| New | +$895K | ﹤0.01% | 2638 |
|
Jim Simons's SBBP Position: Q4 2021 in Review
Jim Simons sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 1,371,400 shares — an estimated $2.8M sold.
Jim Simons first reported a position in SBBP in Q1 2018 and held it in 14 quarters. The position peaked at $5.32M in Q4 2020. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.
- Jim Simons reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
- Jim Simons sold 1,371,400 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $2.8M.
- Jim Simons first reported a position in Strongbridge Biopharma plc. in Q1 2018 and held it in 14 quarters.
- Jim Simons's Strongbridge Biopharma plc. position peaked at $5.32M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.
Based on Renaissance Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.